EUVIMEDEUVIMED entdecken
Crossref

The diphenylpyrimidine derivative as a novel HDAC6 inhibitor alleviates atopic dermatitis through anti-inflammatory effects facilitated via TLR4/MAPK, STAT3 and NF-κB pathways

Jin-Ting Chen, Hao Qiu, Xin-Xin Ran, Wei Cao, Xin Chen, Jin-Ming Gao, Chen-Yu Cao

Bioorganic Chemistry · 2025

DOI: 10.1016/j.bioorg.2025.108451 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bioorganic Chemistry, 2025. Verfasst von Jin-Ting Chen und 6 weiteren Autor:innen. Beteiligte Einrichtung: Shaanxi Key Laboratory of Natural Products & Chemical Biology, College of Chemistry & Pharmacy, Northwest A&F University, Yangling 712100, Shaanxi, C…. Hauptthemen laut MEDLINE: Histone Deacetylase 6, Dermatitis, Atopic, Histone Deacetylase Inhibitors, Pyrimidines. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 46 Literaturangaben. Gefördert von: State Key Laboratory of Natural Medicines, Natural Science Basic Research Program of Shaanxi Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Atopic dermatitis (AD) is a systemic immune disease that primarily affects infants and children, characterized by recurring severe pruritus and chronic eczema. Studies have demonstrated that histone deacetylase 6 inhibitors (HDAC6is) can exhibit anti-inflammatory activities by regulating the acetylation level of target proteins. Building on these findings, our research focused on a synthetic diphenylpyrimidine derivative, specifically 15b, which we identified as a potent HDAC6i and an effective anti-inflammatory agent. This designation was determined by its safety profile, HDAC6 inhibitory activity, selectivity, and its anti-inflammatory effects in lipopolysaccharide (LPS)-stimulated RAW264.7 cells. In 2,4-dinitrochlorobenzene (DNCB)-induced AD mice, daily intraperitoneal injections of 15b significantly alleviated symptoms such as skin edema, dryness, crusting, and peeling, and reduced the frequency of scratching. Moreover, 15b mitigated ear swelling, addressed the increase in epidermal thickness, and reduced mast cell infiltration. Further mechanistic studies revealed that 15b selectively inhibited HDAC6, enhanced the acetylation of α-tubulin and heat shock protein 90 (HSP90) in RAW264.7 cells and BALB/c mice back skin tissue, and attenuated the activation of TLR4/MAPK, STAT3, NF-κB pathways. Consequently, both inflammatory cytokines (IL-4 and IFN-γ) and proteins (iNOS and COX-2) were dose-dependently decreased. These findings suggest that the HDAC6 inhibitor 15b can serve as a potential anti-inflammatory agent for the treatment of AD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Histone Deacetylase 6Dermatitis, AtopicHistone Deacetylase InhibitorsPyrimidinesAnti-Inflammatory AgentsAnti-Inflammatory Agents, Non-SteroidalAnimalsMiceToll-Like Receptor 4NF-kappa BRAW 264.7 CellsSTAT3 Transcription FactorStructure-Activity RelationshipDose-Response Relationship, DrugMolecular StructureMice, Inbred BALB CMitogen-Activated Protein KinasesSignal TransductionDinitrochlorobenzeneLipopolysaccharidesMale

Stichwörter der Autor:innen

Anti-inflammation activityAtopic dermatitisHSP90Histone deacetylase 6 inhibitorα-Tubulin

Substanzen

Histone Deacetylase 6Toll-Like Receptor 4NF-kappa BHistone Deacetylase InhibitorsPyrimidinesSTAT3 Transcription FactorAnti-Inflammatory AgentsHdac6 protein, mouseAnti-Inflammatory Agents, Non-SteroidalTlr4 protein, mouse

Autor:innen und Institutionen

  • Shaanxi Key Laboratory of Natural Products & Chemical Biology, College of Chemistry & Pharmacy, Northwest A&F University, Yangling 712100, Shaanxi, China.
  • Shaanxi Key Laboratory of Natural Products & Chemical Biology, College of Chemistry & Pharmacy, Northwest A&F University, Yangling 712100, Shaanxi, China. Electronic address: chenxin1888@nwsuaf.edu.cn.
  • Shaanxi Key Laboratory of Natural Products & Chemical Biology, College of Chemistry & Pharmacy, Northwest A&F University, Yangling 712100, Shaanxi, China; Northwest A&F University ShenZhen Research Institute, ShenZhen 5…
  • Shaanxi Key Laboratory of Natural Products & Chemical Biology, College of Chemistry & Pharmacy, Northwest A&F University, Yangling 712100, Shaanxi, China. Electronic address: caocy@nwsuaf.edu.cn.

Förderung

  • State Key Laboratory of Natural Medicines
  • Natural Science Basic Research Program of Shaanxi Province

Zitieren

APA

Chen, J. T., Qiu, H., Ran, X. X., Cao, W., Chen, X., Gao, J. M., & Cao, C. Y. (2025). The diphenylpyrimidine derivative as a novel HDAC6 inhibitor alleviates atopic dermatitis through anti-inflammatory effects facilitated via TLR4/MAPK, STAT3 and NF-κB pathways. Bioorganic Chemistry. https://doi.org/10.1016/j.bioorg.2025.108451

Vancouver

Chen JT, Qiu H, Ran XX, Cao W, Chen X, Gao JM, et al. The diphenylpyrimidine derivative as a novel HDAC6 inhibitor alleviates atopic dermatitis through anti-inflammatory effects facilitated via TLR4/MAPK, STAT3 and NF-κB pathways. Bioorganic Chemistry. 2025. doi:10.1016/j.bioorg.2025.108451

BibTeX
@article{Chen2025,
  author = {Chen, Jin-Ting and Qiu, Hao and Ran, Xin-Xin and Cao, Wei and Chen, Xin and Gao, Jin-Ming and Cao, Chen-Yu},
  title = {The diphenylpyrimidine derivative as a novel HDAC6 inhibitor alleviates atopic dermatitis through anti-inflammatory effects facilitated via TLR4/MAPK, STAT3 and NF-κB pathways},
  journal = {Bioorganic Chemistry},
  year = {2025},
  doi = {10.1016/j.bioorg.2025.108451}
}
Kostenlos starten →